Literature DB >> 22065112

The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.

Matthias Prager1, Janine Büttner, Verena Haas, Daniel C Baumgart, Andreas Sturm, Martin Zeitz, Carsten Büning.   

Abstract

PURPOSE: The aetiology of intestinal barrier dysfunction in Crohn's disease (CD) is poorly understood. Associations in relatives of CD families suggest a genetic basis, but the relevant variants are still unknown. We hypothesized that variants in genes occurring in pathways such as autophagy and IL23 signalling might contribute to CD by altering intestinal permeability.
METHODS: We analysed five variants (rs10758669 within JAK2, rs744166 within STAT3, rs4958847, rs11747270 and rs13361189 within IRGM) in adult German inflammatory bowel disease patients (CD, n = 464; ulcerative colitis (UC), n = 292) and matched healthy controls (n = 508). These data were correlated with gastrointestinal permeability as assessed by lactulose/mannitol ratio in CD patients (n = 141) in remission.
RESULTS: Our data confirm the association between JAK2 rs10758669 (p = 0.026, OR = 1.25, 95% CI = 1.04-1.50) and STAT3 rs744166 (p = 0.04, OR = 0.83, 95% CI = 0.688-0.998) with CD, but not UC. With respect to all the analysed IRGM variants, no association was found to either CD or UC. Among CD patients, an increased intestinal permeability was detected in 65 out of 141 patients (46.1%). Most importantly, patients carrying the C risk allele within JAK2 rs10758669 displayed an increased permeability more often compared with patients without the C allele (p = 0.004). No association with intestinal permeability was found for STAT3 rs744166 and all IRGM variants.
CONCLUSIONS: JAK2 rs10758669 and STAT3 rs744166 increase susceptibility for CD. We show that the A>C substitution in rs10758669 of the JAK2 gene is associated with increased intestinal permeability. Altering intestinal barrier function might thus be one mechanism how JAK2 contributes to CD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065112     DOI: 10.1007/s00384-011-1345-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  47 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

3.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

Authors:  J D Söderholm; G Olaison; E Lindberg; U Hannestad; A Vindels; C Tysk; G Järnerot; R Sjödahl
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  Clustering of increased small intestinal permeability in families with Crohn's disease.

Authors:  M Peeters; B Geypens; D Claus; H Nevens; Y Ghoos; G Verbeke; F Baert; S Vermeire; R Vlietinck; P Rutgeerts
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

5.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

7.  Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.

Authors:  J D Söderholm; C Streutker; P-C Yang; C Paterson; P K Singh; D M McKay; P M Sherman; K Croitoru; M H Perdue
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

8.  CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.

Authors:  B R Yacyshyn; J B Meddings
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

9.  Paneth's disease.

Authors:  Jan Wehkamp; Eduard F Stange
Journal:  J Crohns Colitis       Date:  2010-07-06       Impact factor: 10.020

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  20 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  Investigation of JAKs/STAT-3 in lipopolysaccharide-induced intestinal epithelial cells.

Authors:  L Fu; L-W Wei; M-D Zhao; J-L Zhu; S-Y Chen; X-B Jia; S-J Lai
Journal:  Clin Exp Immunol       Date:  2016-08-01       Impact factor: 4.330

Review 3.  Immunology of inflammatory bowel disease and molecular targets for biologics.

Authors:  Maneesh Dave; Konstantinos A Papadakis; William A Faubion
Journal:  Gastroenterol Clin North Am       Date:  2014-09       Impact factor: 3.806

4.  Genetic effects of single nucleotide polymorphisms in JAK2 and STAT5A genes on susceptibility of Chinese Holsteins to mastitis.

Authors:  Tahir Usman; Ying Yu; Chao Liu; Xiao Wang; Qin Zhang; Yachun Wang
Journal:  Mol Biol Rep       Date:  2014-09-10       Impact factor: 2.316

5.  JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.

Authors:  Ji-Xiang Zhang; Jia Song; Jun Wang; Wei-Guo Dong
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

6.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

7.  Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.

Authors:  Tara A Willson; Ingrid Jurickova; Margaret Collins; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

8.  Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population.

Authors:  Li Yang; Dongxiao Liu; Song Liang; Renhua Guo; Zhihong Zhang; Hao Xu; Chao Yang; Yi Zhu
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

9.  Association between variants of the autophagy related gene--IRGM and susceptibility to Crohn's disease and ulcerative colitis: a meta-analysis.

Authors:  Xiao Cheng Lu; Yi Tao; Chen Wu; Peng Lai Zhao; Kai Li; Jin Yu Zheng; Li Xin Li
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Genetic variants associated with Crohn's disease.

Authors:  Sonia Michail; Gilberto Bultron; R William Depaolo
Journal:  Appl Clin Genet       Date:  2013-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.